SRPT logo

Sarepta Therapeutics (SRPT) Total assets

annual total assets:

$3.96B+$698.60M(+21.40%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual total assets is $3.96 billion, with the most recent change of +$698.60 million (+21.40%) on December 31, 2024.
  • During the last 3 years, SRPT annual total assets has risen by +$815.20 million (+25.90%).
  • SRPT annual total assets is now at all-time high.

Performance

SRPT Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

quarterly total assets:

$3.47B-$497.79M(-12.56%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly total assets is $3.47 billion, with the most recent change of -$497.79 million (-12.56%) on March 1, 2025.
  • Over the past year, SRPT quarterly total assets has increased by +$241.00 million (+7.47%).
  • SRPT quarterly total assets is now -12.56% below its all-time high of $3.96 billion, reached on December 31, 2024.

Performance

SRPT quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

SRPT Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.4%+7.5%
3 y3 years+25.9%+13.4%
5 y5 years+117.4%+17.6%

SRPT Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+26.7%-12.6%+15.6%
5 y5-yearat high+117.4%-12.6%+30.2%
alltimeall timeat high>+9999.0%-12.6%>+9999.0%

SRPT Total assets History

DateAnnualQuarterly
Mar 2025
-
$3.47B(-12.6%)
Dec 2024
$3.96B(+21.4%)
$3.96B(+10.1%)
Sep 2024
-
$3.60B(+5.1%)
Jun 2024
-
$3.42B(+6.2%)
Mar 2024
-
$3.22B(-1.2%)
Dec 2023
$3.26B(+4.4%)
$3.26B(+5.0%)
Sep 2023
-
$3.11B(-0.5%)
Jun 2023
-
$3.13B(+2.2%)
Mar 2023
-
$3.06B(-2.2%)
Dec 2022
$3.13B(-0.6%)
$3.13B(-0.9%)
Sep 2022
-
$3.16B(+5.3%)
Jun 2022
-
$3.00B(-1.9%)
Mar 2022
-
$3.06B(-2.9%)
Dec 2021
$3.15B(+5.5%)
$3.15B(+18.2%)
Sep 2021
-
$2.66B(-3.5%)
Jun 2021
-
$2.76B(-0.2%)
Mar 2021
-
$2.77B(-7.4%)
Dec 2020
$2.98B(+63.7%)
$2.98B(+7.3%)
Sep 2020
-
$2.78B(-3.6%)
Jun 2020
-
$2.88B(-2.2%)
Mar 2020
-
$2.95B(+61.7%)
Dec 2019
$1.82B(+11.0%)
$1.82B(+7.1%)
Sep 2019
-
$1.70B(-2.6%)
Jun 2019
-
$1.75B(-11.0%)
Mar 2019
-
$1.96B(+19.6%)
Dec 2018
$1.64B(+25.5%)
$1.64B(+38.8%)
Sep 2018
-
$1.18B(-5.2%)
Jun 2018
-
$1.25B(-4.1%)
Mar 2018
-
$1.30B(-0.6%)
Dec 2017
$1.31B(+208.4%)
$1.31B(+63.4%)
Sep 2017
-
$800.28M(+77.8%)
Jun 2017
-
$450.14M(-12.0%)
Mar 2017
-
$511.53M(+20.6%)
Dec 2016
$424.10M(+54.9%)
$424.10M(-13.0%)
Sep 2016
-
$487.31M(+138.8%)
Jun 2016
-
$204.07M(-4.4%)
Mar 2016
-
$213.36M(-22.1%)
Dec 2015
$273.78M(-7.2%)
$273.78M(+48.2%)
Sep 2015
-
$184.75M(-20.3%)
Jun 2015
-
$231.71M(-4.5%)
Mar 2015
-
$242.71M(-17.7%)
Dec 2014
$295.03M(+1.2%)
$295.03M(-7.5%)
Sep 2014
-
$319.06M(-5.4%)
Jun 2014
-
$337.31M(+22.5%)
Mar 2014
-
$275.39M(-5.5%)
Dec 2013
$291.57M(+42.2%)
$291.57M(-4.2%)
Sep 2013
-
$304.48M(+65.8%)
Jun 2013
-
$183.63M(-5.0%)
Mar 2013
-
$193.34M(-5.7%)
Dec 2012
$204.99M(+277.0%)
$204.99M(+286.2%)
Sep 2012
-
$53.08M(+26.1%)
Jun 2012
-
$42.10M(-9.7%)
Mar 2012
-
$46.65M(-14.2%)
Dec 2011
$54.37M(+18.3%)
$54.37M(-11.0%)
Sep 2011
-
$61.08M(-18.5%)
Jun 2011
-
$74.93M(+59.3%)
Mar 2011
-
$47.03M(+2.3%)
DateAnnualQuarterly
Dec 2010
$45.98M(-23.4%)
$45.98M(-9.6%)
Sep 2010
-
$50.86M(+4.5%)
Jun 2010
-
$48.67M(-7.9%)
Mar 2010
-
$52.83M(-12.0%)
Dec 2009
$60.03M(+135.1%)
$60.03M(-7.8%)
Sep 2009
-
$65.12M(+99.7%)
Jun 2009
-
$32.62M(-11.9%)
Mar 2009
-
$37.02M(+45.0%)
Dec 2008
$25.54M(-33.9%)
$25.54M(-13.5%)
Sep 2008
-
$29.51M(-9.4%)
Jun 2008
-
$32.58M(-8.2%)
Mar 2008
-
$35.48M(-8.2%)
Dec 2007
$38.64M(-5.4%)
$38.64M(+43.8%)
Sep 2007
-
$26.86M(-13.9%)
Jun 2007
-
$31.21M(-11.6%)
Mar 2007
-
$35.31M(-13.6%)
Dec 2006
$40.86M(-27.6%)
$40.86M(-12.2%)
Sep 2006
-
$46.54M(-11.2%)
Jun 2006
-
$52.38M(-9.9%)
Mar 2006
-
$58.12M(+3.0%)
Dec 2005
$56.41M(+97.8%)
$56.41M(+42.7%)
Sep 2005
-
$39.52M(-2.5%)
Jun 2005
-
$40.54M(-11.3%)
Mar 2005
-
$45.70M(+60.2%)
Dec 2004
$28.52M(-39.5%)
$28.52M(-11.9%)
Sep 2004
-
$32.37M(-15.1%)
Jun 2004
-
$38.14M(-16.7%)
Mar 2004
-
$45.80M(-2.8%)
Dec 2003
$47.15M(+64.8%)
$47.15M(+27.0%)
Sep 2003
-
$37.12M(-6.3%)
Jun 2003
-
$39.62M(+85.7%)
Mar 2003
-
$21.33M(-25.4%)
Dec 2002
$28.60M(-15.4%)
$28.60M(-7.0%)
Sep 2002
-
$30.74M(-18.1%)
Jun 2002
-
$37.53M(-16.8%)
Mar 2002
-
$45.14M(+33.5%)
Dec 2001
$33.82M(-3.6%)
$33.82M(+2.0%)
Sep 2001
-
$33.14M(-15.8%)
Jun 2001
-
$39.37M(+29.3%)
Mar 2001
-
$30.46M(-13.2%)
Dec 2000
$35.09M(+172.0%)
$35.09M(-12.3%)
Sep 2000
-
$40.01M(+222.0%)
Jun 2000
-
$12.43M(-21.3%)
Mar 2000
-
$15.79M(+22.4%)
Dec 1999
$12.90M(+26.5%)
$12.90M(+239.5%)
Sep 1999
-
$3.80M(-33.3%)
Jun 1999
-
$5.70M(-28.7%)
Mar 1999
-
$8.00M(-21.6%)
Dec 1998
$10.20M(-45.7%)
$10.20M(-19.0%)
Sep 1998
-
$12.60M(-20.3%)
Jun 1998
-
$15.80M(-9.7%)
Mar 1998
-
$17.50M(-6.9%)
Dec 1997
$18.80M(+347.6%)
$18.80M(-3.1%)
Sep 1997
-
$19.40M(+4.9%)
Jun 1997
-
$18.50M(+400.0%)
Mar 1997
-
$3.70M
Dec 1996
$4.20M
-

FAQ

  • What is Sarepta Therapeutics annual total assets?
  • What is the all time high annual total assets for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual total assets year-on-year change?
  • What is Sarepta Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly total assets year-on-year change?

What is Sarepta Therapeutics annual total assets?

The current annual total assets of SRPT is $3.96B

What is the all time high annual total assets for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual total assets is $3.96B

What is Sarepta Therapeutics annual total assets year-on-year change?

Over the past year, SRPT annual total assets has changed by +$698.60M (+21.40%)

What is Sarepta Therapeutics quarterly total assets?

The current quarterly total assets of SRPT is $3.47B

What is the all time high quarterly total assets for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly total assets is $3.96B

What is Sarepta Therapeutics quarterly total assets year-on-year change?

Over the past year, SRPT quarterly total assets has changed by +$241.00M (+7.47%)
On this page